Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Greiff

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Respiratory Medicine|August 20, 2003
Influence of heavy traffic, city dwelling and socio-economic status on nasal symptoms assessed in a postal population surveyP Montnémery, M Popovic, M Andersson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2006
Obstructive airways diseases, smoking and use of inhaled corticosteroids in southern Sweden in 1992 and 2000R Montnémery, U Nihlén, M Andersson, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1995
Allergen challenge-induced entry of alpha 2-macroglobulin and tryptase into human nasal and bronchial airwaysC Svensson, R Grönneberg, M Andersson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 10, 2002
Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitisM van Hage-Hamsten, E Johansson, A Roquet, et al.
Allergy|March 1, 1997
Epithelium, microcirculation, and eosinophils--new aspects of the allergic airway in vivoC G Persson, J S Erjefält, M Andersson, et al.
Scandinavian Journal of Immunology|November 25, 2005
Blockade of CTLA-4 promotes airway inflammation in naive mice exposed to aerosolized allergen but fails to prevent inhalation toleranceL Alenmyr, V Matheu, L Uller, et al.
Scandinavian Journal of Immunology|May 26, 1998
Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airwaysC G Persson, J S Erjefält, L Greiff, et al.
American Journal of Respiratory and Critical Care Medicine|July 3, 1999
Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airwaysJ S Erjefält, L Greiff, M Andersson, et al.
Rhinology|March 1, 1995
A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitisM Andersson, R Berglund, L Greiff, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 1991
Plasma exudation as a first line respiratory mucosal defenceC G Persson, I Erjefält, U Alkner, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Respiratory Medicine|August 20, 2003
Influence of heavy traffic, city dwelling and socio-economic status on nasal symptoms assessed in a postal population surveyP Montnémery, M Popovic, M Andersson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2006
Obstructive airways diseases, smoking and use of inhaled corticosteroids in southern Sweden in 1992 and 2000R Montnémery, U Nihlén, M Andersson, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1995
Allergen challenge-induced entry of alpha 2-macroglobulin and tryptase into human nasal and bronchial airwaysC Svensson, R Grönneberg, M Andersson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 10, 2002
Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitisM van Hage-Hamsten, E Johansson, A Roquet, et al.
Allergy|March 1, 1997
Epithelium, microcirculation, and eosinophils--new aspects of the allergic airway in vivoC G Persson, J S Erjefält, M Andersson, et al.
Scandinavian Journal of Immunology|November 25, 2005
Blockade of CTLA-4 promotes airway inflammation in naive mice exposed to aerosolized allergen but fails to prevent inhalation toleranceL Alenmyr, V Matheu, L Uller, et al.
Scandinavian Journal of Immunology|May 26, 1998
Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airwaysC G Persson, J S Erjefält, L Greiff, et al.
American Journal of Respiratory and Critical Care Medicine|July 3, 1999
Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airwaysJ S Erjefält, L Greiff, M Andersson, et al.
Rhinology|March 1, 1995
A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitisM Andersson, R Berglund, L Greiff, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 1991
Plasma exudation as a first line respiratory mucosal defenceC G Persson, I Erjefält, U Alkner, et al.
Pageof 10